Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Glukokortikoidinduceret diabetes og risikofaktorer under højdosisbehandling

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Metastaserende basalcellekarcinom

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Endoskopisk behandling af hydrocefalus

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Intracerebral hæmoragi tolv dage efter vaccination med ChAdOx1 nCoV-19

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Selvskade er et stigende problem, men der er håb forude

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Methods for collecting upper respiratory tract specimens for COVID-19 diagnostics

    Research output: Contribution to journalReviewResearchpeer-review

  1. Does nocturnal hypoglycaemia really improve quality of life? Reply to Søholm U, Broadley MM, Choudhary P et al [letter]

    Research output: Contribution to journalLetterResearchpeer-review

  2. Acute hypoglycemia and risk of cardiac arrhythmias in insulin-treated type 2 diabetes and controls

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. EDUCATION PROGRAMMES FOR PERSONS WITH TYPE 1 DIABETES USING AN INSULIN PUMP: A SYSTEMATIC REVIEW

    Research output: Contribution to journalReviewResearchpeer-review

  4. Cold-induced dishabituation in rodents exposed to recurrent hypoglycaemia

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

This review describes the cumulative incidence (CI) and risk factors of glucocorticoid (GC)-induced diabetes in patients commencing high-dose GC therapy: ≥ 30 mg prednisolone/day. Finally, methods of screening are discussed. In 13 studies, the CI of GC-induced diabetes ranges 12-65%, but with the current diagnostic criteria the CI is assessed to be 30-50%. Risk factors may include high age and high levels of BMI and glycated haemoglobin, respectively, before GC therapy. It is important to acknowledge, that hyperglycaemia in GC therapy is more prevalent postprandially, and screening should be planned accordingly.

Translated title of the contributionGlucocorticoid-induced diabetes and risk factors during high-dose therapy
Original languageDanish
Article numberV06170454
JournalUgeskrift for Laeger
Volume180
ISSN0041-5782
Publication statusPublished - 2018

ID: 54747817